Impacts of COVID-19 pandemic on culture-proven sepsis in neonates
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1391929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Xiaofeng Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: COVID-19, Neonatal Sepsis, SARS-CoV-2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Soochow University.
Themen: Sepsis
Abstract (Originalsprache)
Objective
To assess the effects of COVID-19 pandemic on the epidemiology of neonatal sepsis and the antibiotic resistance profiles of pathogens involved.
Methods
This retrospective cohort study analyzed infants diagnosed with culture-proven sepsis at the neonatal department of a tertiary children’s hospital in East China from January 2016 to December 2022. We compared the clinical and microbiological characteristics of neonatal sepsis cases between the pre-pandemic Phase I (2016–2019) and during the COVID-19 pandemic Phase II (2020–2022).
Results
A total of 507 infants with 525 sepsis episodes were included, with 343 episodes in Phase I and 182 in Phase II. The incidence of early-onset sepsis (EOS) was significantly lower during Phase II (p < 0.05). Infants in Phase II had lower gestational ages and birth weights compared to Phase I. Clinical signs such as mottled skin, severe anemia, thrombocytopenia were more prevalent in Phase II, alongside a higher incidence of complications. Notably, necrotizing enterocolitis (NEC) (p < 0.05) and meningitis (p < 0.1) occurred more frequently during Phase II. Escherichia coli ( E. coli ) and Klebsiella pneumoniae ( K. pneumoniae ) were the predominant pathogens isolated from infants of death and cases with complications. A significant decrease in the proportion of K. pneumoniae was observed in Phase II, alongside increased antibiotic resistance in both E. coli and K. pneumoniae . The period of the COVID-19 pandemic (Phase II) was identified as an independent risk factor for complications in infants with neonatal sepsis.
Conclusion
COVID-19 pandemic response measures correlated with a decrease in EOS and an increase in neonatal sepsis complications and antibiotic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of Pediatrics, Richmond University Medical Center, Staten Island, NY, United States.
- Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Förderung
- Soochow University
Zitieren
APA
Yang, X., Ren, L., Gong, M., Lu, Y., & Ding, X. (2024). Impacts of COVID-19 pandemic on culture-proven sepsis in neonates. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1391929
Vancouver
Yang X, Ren L, Gong M, Lu Y, Ding X. Impacts of COVID-19 pandemic on culture-proven sepsis in neonates. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1391929
BibTeX
@article{Yang2024,
author = {Yang, Xiaofeng and Ren, Luxin and Gong, Min and Lu, Yanhong and Ding, Xin},
title = {Impacts of COVID-19 pandemic on culture-proven sepsis in neonates},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1391929}
}
EUVIMED